Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.

Howell I. et al, (2024), J allergy clin immunol

Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23.

Cane J. et al, (2024), J infect

Anti-inflammatory effects of oral prednisolone at stable state in people treated with mepolizumab: a proteomic and bulk transcriptomics analysis

Howell I. et al, (2024)

Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23

Cane J. et al, (2023)

Additional effects of oral prednisolone following mepolizumab on the nasal transcriptome

Howell I. et al, (2023), Airway cell biology and immunopathology

Method development for flow-cytometric analysis of primary human airway epithelia infected with non-typeable Haemophilus influenzae

Horton KL. et al, (2022), 03.02 - airway cell biology and immunopathology

Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies.

Jabeen MF. et al, (2022), Microbiol spectr

A randomised clinical trial of azithromycin versus standard care in ambulatory COVID-19 – the ATOMIC2 trial

Hinks T. et al, (2021), Thorax, 76

Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.

Hinks TSC. et al, (2021), Lancet respir med, 9, 1130 - 1140

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Ramakrishnan S. et al, (2021), Respiratory infections and bronchiectasis

Tight junction molecules are unresponsive in the epithelium of COPD patients during RV infection

Lababidi R. et al, (2021), Mechanisms of lung injury and repair

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells

Zhuang X. et al, (2021), Iscience, 103144 - 103144

The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.

Zhuang X. et al, (2021), Biorxiv

Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV1

Cane JL. et al, (2021), International journal of chronic obstructive pulmonary disease, Volume 16, 1437 - 1447

A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 Trial

Hinks TSC. et al, (2021), Ssrn electronic journal

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.

Ramakrishnan S. et al, (2021), Lancet respir med

Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial

Ramakrishnan S. et al, (2021)

Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled Trial

Ramakrishnan S. et al, (2021)

Interferon responses are dysfunctional in the epithelium of COPD Patients

Lababidi R. et al, (2020), Airway cell biology and immunopathology

P13 Exhaled nitric oxide and blood eosinophil count in predicting sputum inflammatory type in a heterogeneous airways disease population

Lehtimäki L. et al, (2019), Asthma: endotypes/biomarkers

Load More

Include forthcoming?